Sientra Stock News

Las Vegas, USA, March 15, 2022 (GLOBE NEWSWIRE) -- Breast Implants Market is Contemplated to Surge at a Tremendous CAGR of 7.00% by 2026, Asserts DelveInsight The increase in demand for Breast Implants is predominantly attributed to the growing prevalence of breast cancer among the population across the globe. In addition, the rising number of people demanding cosmetic surgeries mainly women to enhance their aesthetic appeal could also be a potential factor for increasing the Breast Implants market. Moreover, an increase in the number of breast augmentation surgeries and technological advancement in the product portfolio is expected to bolster the Breast Implant market during the forecasted period. DelveInsight''s Breast Implants Market Insights and Forecast report provides the current and forecast of Breast Implants, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Breast Implants Market scenario.

During the last session, Sientra Inc. (NASDAQ:SIEN)’s traded shares were 0.44 million, with the beta value of the company hitting 2.04. At the end of the trading day, the stock’s price was $2.31, reflecting an intraday loss of -3.75% or -$0.09. The 52-week high for the SIEN share is $9.14, that puts it down -295.67 … Boom Or Bust: Where Does Sientra Inc. (NASDAQ: SIEN) Stock Go From Here? Read More »

SANTA BARBARA, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the fourth quarter and full year of 2021 after the close of trading on Wednesday, March 23, 2022. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.

SANTA BARBARA, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the ar

Sientra Inc (SIEN) shares closed 0.6% lower than its previous 52 week low, giving the company a market cap of $187M. The stock is currently down 12.3% year-to-date, down 19.3% over the past 12 months, and down 62.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 11.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 293.6% The company's stock price performance over the past 12 months lags the peer average by -158.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The U.S. plastic surgery market is thought to be worth around $13 billion. With its new acquisition, Sientra (SIEN) will be hoping to improve its positioning in thi

Sientra Inc (SIEN) shares closed 4.2% lower than its previous 52 week low, giving the company a market cap of $201M. The stock is currently down 5.7% year-to-date, down 10.6% over the past 12 months, and down 59.8% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 20.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -598.4% The company's stock price performance over the past 12 months lags the peer average by -126.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

SANTA BARBARA, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art

Royal Bank of Canada trimmed its position in shares of Sientra, Inc. (NASDAQ:SIEN) by 19.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 26,170 shares of the medical instruments supplier’s stock after selling 6,284 shares during the quarter. Royal Bank […]

Wall Street analysts expect Sientra, Inc. (NASDAQ:SIEN) to report sales of $19.90 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Sientras earnings. Sientra reported sales of $22.64 million in the same quarter last year, which indicates a negative year-over-year growth rate of 12.1%. The firm is expected []

Metropolitan Life Insurance Co NY grew its stake in Sientra, Inc. (NASDAQ:SIEN) by 45,920.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,903 shares of the medical instruments suppliers stock after purchasing an additional 6,888 shares during the quarter. Metropolitan Life []

SANTA BARBARA, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (Sientra or the Company), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it has entered into exclusive agreements with Kai Aesthetics, Inc., and Paragon Meditech Company for the distribution of Sientras breast implants in Canada and China, respectively. 1

Global Breast Reconstruction Market Synopsis: According to the world class Breast Reconstruction Market report, the leading players are focusing more on offering products at rational prices to gain a competitive advantage over the other players in the Healthcare industry. The main

Charles Schwab Investment Management Inc. lifted its holdings in shares of Sientra, Inc. (NASDAQ:SIEN) by 8.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 142,936 shares of the medical instruments suppliers stock after buying an additional 11,364 shares during the quarter. Charles []

Wall Street analysts forecast that Sientra, Inc. (NASDAQ:SIEN) will announce sales of $19.90 million for the current quarter, according to Zacks. Two analysts have provided estimates for Sientras earnings. Sientra posted sales of $22.64 million in the same quarter last year, which would indicate a negative year over year growth rate of 12.1%. The firm []